North Central London
Joint Formulary
 
back
8 Malignant disease and immunosuppression

The formulary for systemic anti-cancer treatments should be viewed alongside the 'National Cancer Drugs Fund list'

https://www.england.nhs.uk/publication/national-cancer-drugs-fund-list/

08-02-02 Corticosteroids and other immunosuppressants

Antithymocyte immunoglobulin - rabbit Thymoglobuline®
Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Renal transplant: For transplant induction and rejection
    • Liver transplant: For transplant rejection only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA481 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in children and young people
 

Restricted Drug View adult BNF  View SPC online  View childrens BNF  HCD
Basiliximab
Restricted

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • This medicine has a positive NICE Technology Appraisal but service is not offered at NMUH.
    • Check MHRA Drug Safety Alerts
  • RFL:
    • Prior funding required for treatment of lymphoma with radiolabelled basiliximab.
    • Approved for Renal (as per TA) and Liver (contact Pharmacy) for transplant patients.
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA481: Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482: Immunosuppressive therapy for kidney transplant in children and young people
 

Restricted Drug GP - Red View adult BNF  View SPC online  View childrens BNF  HCD
Ciclosporin Capimune®
Formulary

GP-RedRed (hospital only prescribing) for renal transplant

Grey for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary

View adult BNF  View SPC online  View childrens BNF
Ciclosporin Capsorin®
Formulary

GP-RedRed (hospital only prescribing) for renal transplant

Grey for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary

View adult BNF  View SPC online  View childrens BNF
Ciclosporin Deximune®
Formulary

GP-RedRed (hospital only prescribing) for renal transplant

Grey for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

 

Provider notes

  • NMUH:

    • No restriction stated
  • RFL:

    • Liver transplant: Preferred brand for new patients
    • Renal transplant: Not for new patients
    • Transplant patients must be maintained on the same brand
  • RNOH:

    • Non-formulary
  • UCLH:
  • WH:

    • Non-formulary

View adult BNF  View SPC online  View childrens BNF
Ciclosporin Neoral®
Formulary

GP-RedRed (hospital only prescribing) for renal transplant

Grey for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

 

Provider notes

  • NMUH:

    • Restricted to Consultant use only.
  • RFL:

    • Liver transplant: Not for new patients unless liquid formulation required
    • Renal transplant: Preferred brand for renal transplant
    • Transplant patients must be maintained on the same brand
  • RNOH:

    • Non-formulary
  • UCLH:
  • WH:

    • Non-formulary

View adult BNF  View SPC online  View childrens BNF
Ciclosporin Sandimmun®
Formulary

GP-RedRed (hospital only prescribing) for renal transplant

Grey for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

 

Provider notes

  • NMUH:

    • No restriction stated
  • RFL:

    • Liver transplant: Not for new patients
    • Renal transplant: Not for new patients
    • Transplant patients must be maintained on the same brand
  • RNOH:

    • Non-formulary
  • UCLH:
  • WH:

    • Non-formulary

View adult BNF  View SPC online  View childrens BNF
Sirolimus
Formulary

GP-Red Red (hospital only prescribing) for all new transplants, except liver

GP-Grey Red for existing transplants and liver transplants

See NICE TA for eligibility criteria

 

Provider notes

  • NMUH:

    • See links below
    • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
  • RFL:

    • Approved for renal and liver transplants
  • RNOH:

    • Non-formulary
  • UCLH:
  • WH:

    • Non-formulary
Link  NICE TA481 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF  HCD
Tacrolimus Adoport®
Formulary

GP-Red Red (hospital only prescribing) for all new transplants, except liver

GP-Grey Red for existing transplants and liver transplants

 

Provider notes

  • NMUH:
    • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
  • RFL:

    • Liver transplant: Preferred brand for new patients
    • Kidney transplant: Preferred brand for patients
    • Transplant patients must be maintained on the same brand
  • RNOH:

    • Non-formulary
  • UCLH:
  • WH:

    • Non-formulary
Link  NICE TA481: Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482: Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF
Tacrolimus Modigraf®
Formulary

GP-Red Red For all new transplants, except liver

GP-Grey Red Existing transplants and liver transplants

Provider notes

  • NMUH:
    • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA481: Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482: Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF
Tacrolimus Prograf®
Restricted

GP-Red Red For all new transplants, except liver

GP-Grey Red Existing transplants and liver transplants

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Historic transplant patients
    • Transplant patients must be maintained on the same brand
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA481: Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482: Immunosuppressive therapy for kidney transplant in children and young people
Link  NMUH: Trust Therapeutic Drug Monitoring Guidelines
 

Restricted Drug View adult BNF  View SPC online  View childrens BNF
Tacrolimus Vivadex®
Formulary

GP-Red Red For all new transplants, except liver

GP-Grey Red Existing transplants and liver transplants

Provider notes

  • NMUH:
    • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA481: Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482: Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF
Tacrolimus modified release Advagraf®
Formulary

GP-Red Red For all new transplants, except liver

GP-Grey Red Existing transplants and liver transplants

Provider notes

  • NMUH:
    • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
  • RFL:
    • Historic transplant patients
    • Transplant patients must be maintained on the same brand
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA481 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF
Tacrolimus modified release Envarsus®
Formulary

GP-Red Red For all new transplants, except liver

GP-Grey Red Existing transplants and liver transplants

Provider notes

  • NMUH:
    • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
  • RFL:
    • Approved for immunosuppression in liver and renal transplants for patient in whom once-daily tacrolimus is indicated. For RFL only (approved by DTC in May-16, ratified by JFC in June-16)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA481 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF
Belatacept
Non Formulary
Link  NICE TA481 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF  HCD
Everolimus Certican®
Non Formulary

DO NOT CONFUSE Afinitor®, Votubia AND Certican AS THEY ARE LICENSED FOR DIFFERENT INDICATIONS

Link  NICE TA348 (not recommended): Everolimus for preventing organ rejection in liver transplantation
Link  NICE TA481 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482 (not recommended as initial treatment): Immunosuppressive therapy for kidney transplant in children and young people
 

View adult BNF  View SPC online  View childrens BNF  HCD
Tacrolimus caps
Non Formulary

Not approved for Chronic Histiocytic Intervillosities (JFC March 2019)


Black View adult BNF  View SPC online  View childrens BNF